 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
* u' O# ~4 o7 B! v # y' U/ y# ]9 a- \' c
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
; w5 m8 Q( D. q4 }
: W0 g& G" k& \# p- _BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
9 C9 u$ e- E& p+ q( E/ b
- u# p$ C! O0 F* W) E, t5 s; j$ I' Z
( M$ Q" c$ U- ~6 vEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
, h! Y+ G% U5 J5 ]/ z3 C! H4 @1 P" Z$ w7 t, u
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
- G/ N( V& H) Y6 {4 Y% k1 A. v- p
e. `. k" o! e s3 e" q5 RThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.0 H! K& v9 }- g+ ?4 z: k
- `; y- F4 f( f1 o
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
+ A/ H4 x7 t, R2 X/ H, w6 W/ b4 H3 Q4 r0 b8 S/ F
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.: I3 m5 C E& R* v) w/ Q( J8 T
, ?) ^5 n5 O N2 W H3 f"As a scientist, it's one of the highlights of my CAREER," Shan said.$ j1 [( K: _# _! [
: u) q: |# y2 ?. C
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention.". Z3 K" W1 |; d' o1 T
# p/ D6 \7 y$ I; e, IIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.% J5 c0 s( A: w. x" p) }" L
; o, n7 G% v! |* NGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.6 b3 h$ f4 w$ ~
! K3 G9 h: \+ f/ i/ ` o
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
( u9 l, P! e2 }# `, ~( l3 d3 o3 r+ l/ E/ i' l7 _' @
3 Q* e$ X/ S9 ^6 F" O' y0 Shttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|